EGFR and cancer: PPI network, GO, and KEGG pathway analyses exhibited that SEMA4C and SEMA4C-related proteins could modulate chemotaxis, cell morphogenesis and differentiation, focal adhesion, cancer-related proteoglycans, oncogenic signaling pathways, VEGF signaling pathway, adherens junctions, and the ErbB signaling pathway.